Isolation of prostate cancer cell subpopulations of functional interest by use of an on-chip magnetic bead-based cell separator

Journal of Micromechanics and Microengineering

Volumn 19, Issue 9, 2009, Pages

  Estes, Matthew D ^a   Ouyang, Bin ^b   Ho, Shuk Mei ^b   Ahn, Chong H ^a  

^a University of Cincinnati   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL POPULATIONS; CELL SEPARATION; CELL SEPARATORS; CELL SORTING; CYCLIC OLEFIN COPOLYMERS; FUSION BONDING; INCUBATION TIME; MAGNETIC BEADS; MULTIPLE SURFACES; NICKEL-IRON ELECTROPLATING; ON CHIPS; PROSTATE CANCER CELLS; PROSTATE CANCERS; PROSTATE-SPECIFIC MEMBRANE ANTIGENS; SEPARATION DEVICES; SORTING PROCEDURE; SURFACE MARKERS;

BIOASSAY; BIOCHIPS; CELL CULTURE; CELL PROLIFERATION; IRON PLATING; OLEFINS;

SEPARATION;

EID: 70350686506     PISSN: 09601317     EISSN: 13616439     Source Type: Journal    
DOI: 10.1088/0960-1317/19/9/095015     Document Type: Article

References (54)

1. Breslow N et al 1977 Latent carcinoma of prostate at autopsy in seven areas Int. J. Cancer 20 680-8
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari R C, Ghafoor A, Feuer E J and Thun M J 2005 Cancer statistics Cancer J. Clin. 55 10-30 2005
3. Liu A Y and Peehl D M 2001 Characterization of cultured human prostatic epithelial cells by cluster designation antigen expression Cell Tissue Res. 305 389-97
4. Liu A Y, Roudier M P and True L D 2004 Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile Am. J. Pathol. 165 1543-56
5. Landers K A, Burger M J, Tebay M A, Purdie D M, Scells B, Samaratunga H, Lavin M F and Gardiner R A 2004 Use of multiple biomarkers for a molecular diagnosis of prostate cancer Int. J. Cancer 114 950-6
6. Horoszewicz J S et al 1980 The human prostatic carcinoma cell line LNCaP and its derivatives Prog. Clin. Biol. Res. 37 115-32
7. Van Steenbrugge G J, Van Uffelen C J C, Bolt J and Schroder F H 1991 The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity J. Steroid Biochem. Mol. Biol. 40 207-14
8. Schuurmans L G, Bolt J, Veldscholte J and Mulder E 1991 Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones J. Steroid Biochem. Mol. Biol. 40 193-7
9. Horoszewicz J S, Leong S S, Kawinski E, Karr J P, Rosenthal H, Chu T M, Mirand E A and Murphy G P 1983 LNCaP model of human prostatic carcinoma Cancer Res. 43 1809-18
10. Fizazi K and Navone N M 2005 Preclinical models of prostate cancer Bull. Cancer 92 129-41
11. Liu A Y 2000 Differential expression of cell surface molecules in prostate cancer cells Cancer Res. 60 3429-34
12. Silverstein A M 1989 A History of Immunology (New York: Academic)
13. Zola H 1999 The CD nomenclature-a brief historical summary of the CD nomenclature, why it exists and how CDs are defined J. Biol. Regul. Homeost. Agents 13 226-8
14. Liu A Y and True L D 2002 Characterization of prostate cell types by CD cell surface molecules Am. J. Pathol. 160 37-43
15. Hall C L, Bafico A, Dai J, Aaronson S A and Keller E T 2005 Prostate cancer cells promote osteoblastic bone metastases through WNTS Cancer Res. 65 7554-60
16. Kinoshita Y, Kuratsukuri K, Landas S, Imaida K, Rovito P M, Wang C Y and Haas G P 2006 Expression of prostate-specific membrane antigen in normal and malignant human tissues World J. Surg. 30 628-36
17. Chang S S 2004 Overview of prostate-specific membrane antigen Rev. Urol. 6 13-8
18. Olson W C, Heston W D W and Rajasekaran A K 2007 Clinical trials of cancer therapies targeting prostate-specific membrane antigen Rev. Rec. Clin. Trials 2 182-90
19. Carter R E, Feldman A R and Coyle J T 1996 Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase Proc. Natl. Acad. Sci. 93 749-53
20. Rajasekaran A K, Anilkumar G and Christiansen J J 2005 Is prostate-specific membrane antigen a multifunctional protein? Am. J. Physiol. 288 975-81
21. Ghosh A, Wang X, Klein K and Heston W D 2005 Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness Cancer Res. 65 727-31
22. Perner S, Hofer M D, Kim R, Shah R B, Li H, Moller P, Hautmann R E, Gschwend J E, Kuefer R and Rubin M A 2007 Prostate-specific membrane antigen expression as a predictor of prostate cancer progression Hum. Pathol. 38 696-701
23. Leach F 2004 Targeting prostate-specific membrane antigen in cancer therapy: can molecular medicine be brought to the surface? Cancer Biol. Ther. 3 559-60
24. Dall'Era M A, Oudes A, Martin D B and Liu A Y 2007 HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells Prostate 67 714-21
25. Ciocca D R and Calderwood S K 2005 Heat shock proteins in cancer: diagnostic, prognostic, predictive and treatment implications Cell Stress Chaperones 10 86-103
26. Rocchi P, So A, Kojima S, Signaevsky M, Beraldi E, Fazli L, Hurtado-coll A, Yamanaka K and Gleave1 M 2004 Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer Cancer Res. 64 6595-6602
27. Sun Y and MacRae T H 2005 The small heat shock proteins and their role in human disease FEBS J. 272 2613-27 (Pubitemid 40825410)
28. Tawfic S, Niehans G A and Manivel J C 2003 The pattern of CD10 expression in selected pathologic entities of the prostate gland Hum. Pathol. 34 450-6
29. Osman I, Yee H, Taneja S S, Levinson B, Zeleniuch-Jacquotte A, Chang C, Nobert C and Nanus D M 2004 Neutral endopeptidase protein expression and prognosis in localized prostate cancer Clin. Cancer Res. 10 4096-4010
30. Dall'Era M A, True L D, Siegel A F, Porter M P, Sherertz T M and Liu A Y 2007 Differential expression of CD10 in prostate cancer and its clinical implication BMC Urol. 7 3
31. Liu A Y, Brubaker K D, Goo Y A, Quinn J E, Kral S, Sorensen C M, Vessella R L, Belldegrun A S and Hood L E 2004 Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines Prostate 60 98-108
32. Papandreou C N et al 1998 Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression Nat. Med. 4 50-7
33. Song J, Aumuller G, Xiao F, Wilhelm B and Albrecht M 2004 Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells Prostate 58 394-405
34. Lim H W, Hong S, Jin W, Lim S, Kim S J, Kang H J, Park E H, Ahn K and Lim C J 2005 Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells Exp. Mol. Med. 37 497-506
35. Estes M D, Do J and Ahn C H 2009 On chip cell separator using magnetic bead-based enrichment and depletion of various surface markers Biomed. Microdevices 11 509-15
36. Do J and Ahn C H 2008 A polymer lab-on-a-chip for magnetic immunoassay with on-chip sampling and detection capabilities Lab. Chip 8 542-9
37. Freedland S J et al 2003 Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer Prostate 55 71-80
38. Wang Z P, Eisenberger M A, Carducci M A, Partin A W, Scher H I and Ts'o P O P 2000 Identification and characterization of circulating prostate carcinoma cells Cancer 8 2787-95
39. Duffy D C, McDonald J C, Schueller O J A and Whitesides G M 1998 Rapid prototyping of microfluidic systems in poly(dimethylsiloxane) Anal. Chem. 70 4974-84
40. Kim D S, Lee S H, Ahn C H, Lee J Y and Kwon T H 2006 Disposable integrated microfluidic biochip for blood typing by plastic microinjection molding Lab. Chip 6 794-802
41. Wabuyele M B, Ford S M, Stryjewski W, Barrow J and Soper S A 2001 Single molecule detection of double-stranded DNA in poly(methylmethacrylate) and polycarbonate microfluidic devices Electrophoresis 18 3939-48
42. Choi J W, Ahn C H, Bhansali S and Henderson H T 2000 A new magnetic bead-based, filterless bio-separator with planar electromagnet surfaces for integrated bio-detection systems Sensors Actuators 68 34-9
43. Choi J W et al 2001 Development and characterization of microfluidic devices and systems for magnetic bead-based biochemical detection Biomed. Microdevices 3 191-200
44. Ahn C H, Choi J W, Beaucage G, Nevin J, Lee J B, Puntambekar A and Lee J Y 2004 Disposable smart lab on a chip for point-of-care clinical diagnostics Proc. IEEE 92 154-73
45. Choi J W et al 2001 A plastic micro injection molding technique using replaceable mold-disks for disposable microfluidic systems and biochips Proc. Micro-TAS 2001 pp 411-2
46. Becke H and Dietz W 1998 Microfluidic devices for u-TAS applications fabricated by polymer hot embossing Proc. SPIE Conf. on Microfluidic Devices pp 177-18247
47. Liakopoulos T 2000 Magnetic MEMS-based microstructures and sensors using a new thick photolithography technique PhD Thesis University of Cincinnati pp 2683-895
48. Hong C C, Choi J W and Ahn C H 2004 A novel in-plane passive microfluidic mixer with modified Tesla structures Lab. Chip 4 109-13
49. Choi J W, Oh K H, Thomas J H, Heineman W R, Halsall H B, Nevin J H, Helmicki A J, Henderson H T and Ahn C H 2002 An integrated microfluidic biochemical detection system for protein analysis with magnetic bead-based sampling capabilities Lab. Chip 2 27-30
50. Puntambekar A, Murugesan S, Trichur R, Cho H, Kim S, Choi J W and Ahn C H 2002 Effect of surface modification on thermo-plastic fusion bonding for 3-D microfluidics Proc. Micro-TAS 2002 pp 425-42
51. Albrecht M, Mittler A, Wilhelm B, Lundwall A, Lilja H, Aumüller G and Bjartell A 2003 Differential expression of CD10 in prostate cancer and its clinical implication Eur. Urol. 44 415-22
52. Saias L, Saliba A E, Pierga J Y, Viehl P, Farace F and Viovy J L 2008 Microfluidic magnetic cell sorting system for cancer diagnosis Proc. Micro-TAS 2008 pp 552-4
53. Liu Y J, Guo S S, Zhang Z L, Huang W H, Baigl D, Xie M, Chen Y and Pang D W 2007 A micropillar-integrated smart microfluidic device for specific capture and sorting of cells Electrophoresis 28 4713-22
54. Martin Henao G A, Picon M, Amill B, Querol S, Ferra C, Granena A and Garcia J 2001 Combined positive and negative cell selection from allogeneic peripheral blood progenitor cells (PBPC) by use of immunomagnetic methods Bone Marrow Transplant. 27 683-7